Sorafenib-Induced Psoriasiform Eruption in a Patient With Metastatic Thyroid Carcinoma

被引：0

作者：

Diamantis, Melissa L. ^{[1
]}

Chon, Susan Y. ^{[2
]}

机构：

[1] Univ Texas Houston, Sch Med, Houston, TX 77030 USA

[2] Univ Texas Houston, MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA

来源：

JOURNAL OF DRUGS IN DERMATOLOGY | 2010年 / 9卷 / 02期

关键词：

INFLAMMATION; INHIBITOR; SUNITINIB; RECEPTOR; THERAPY;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Sorafenib is a multikinase inhibitor that blocks tumor cell proliferation and angiogenesis and is used for the treatment of advanced renal cell carcinoma, unresectable hepatocellular carcinoma, and other solid tumors Various dermatologic side effects have been reported, most notably a hand-foot-skin reaction (HFSR) This is a case of a sorafenib-induced psoriasiform eruption in a patient with metastatic thyroid carcinoma This patient also developed cutaneous squamous cell carcinoma and HFSR in association with sorafenib To the authors' knowledge, a psoriasiform eruption due to sorafenib has not been reported in the literature and has important therapeutic implications

引用

页码：169 / 171

页数：3

共 50 条

[1] Sorafenib-Associated Psoriasiform Eruption in a Patient With Hepatocellular Carcinoma
Ilknur, Turna
Akarsu, Sevgi
Carsanbali, Saim
Lebe, Banu
Fetil, Emel
JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (08) : 899 - 900
[2] Sorafenib-induced Facial Acneiform Eruption
Mijares, Maria C.
Aldahan, Adam S.
Gonzalez, Hector H.
Jaimes, Juan P.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (04)
[3] Sorafenib-induced thyroid dysfunction
Reactions Weekly, 2015, 1555 (1) : 6 - 6
[4] Sorafenib-induced erythema multiforme in metastatic renal cell carcinoma
Bilac, Cemal
Muezzinoglu, Talha
Ermertcan, Aylin Tuerel
Kayhan, Tuba Celebi
Temeltas, Goekhan
Ozturkcan, Serap
Temiz, Peyker
CUTANEOUS AND OCULAR TOXICOLOGY, 2009, 28 (02) : 90 - 92
[5] Sorafenib-Induced Acute Pancreatitis in a Patient with Differentiated Thyroid Cancer
Kattah Martinez, Laura Ximena
Marin Carrillo, Lisseth Fernanda
Rojas Melo, Leonardo
EUROPEAN THYROID JOURNAL, 2018, 7 (03) : 145 - 148
[6] Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma
Kodaira, M.
Takahashi, S.
Takeuchi, K.
Yuasa, T.
Saotome, T.
Yonese, J.
Fukui, I.
Hatake, K.
ANNALS OF ONCOLOGY, 2010, 21 (07) : 1563 - 1565
[7] Sorafenib-Induced Tumor Response in a Patient With Metastatic Epithelioid Angiomyolipoma
Lee, Dae-Won
Chang, Hyun
Kim, Yu-Jung
Kim, Kwhan-Mien
Lee, Hee-Jin
Lee, Jong-Seok
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (11) : E42 - E45
[8] Sorafenib-Induced Eruption Mimicking Erythema Multiforme
Pichard, Dominique C.
Cardones, Adela R.
Chu, Emily Y.
Dahut, William L.
Kong, Heidi H.
JAMA DERMATOLOGY, 2016, 152 (02) : 227 - 228
[9] Case of Sorafenib-Induced Thyroid Storm
Haraldsdottir, Sigurdis
Li, Quan
Villalona-Calero, Miguel A.
Olencki, Thomas E.
Kendra, Kari
Ing, Steven W.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (16) : E262 - E264
[10] Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma
Dogan, Erkan
Aksoy, Sercan
Arslan, Cagatay
Dede, Didem S.
Altundag, Kadri
MEDICAL ONCOLOGY, 2010, 27 (04) : 1436 - 1437

← 1 2 3 4 5 →